M&A Deal Summary

JSS Medical Research Acquires Bonne Santé Sp. z o.o.

On June 6, 2016, JSS Medical Research acquired life science company Bonne Santé Sp. z o.o.

Acquisition Highlights
  • This is JSS Medical Research’s 4th transaction in the Life Science sector.
  • This is JSS Medical Research’s 1st transaction in Poland.

M&A Deal Summary

Date 2016-06-06
Target Bonne Santé Sp. z o.o.
Sector Life Science
Buyer(s) JSS Medical Research
Deal Type Add-on Acquisition

Target

Bonne Santé Sp. z o.o.

Warsaw, Poland
Bonne Santé Sp. z o.o. is a provider of clinical research services for international pharmaceutical companies for Phase II-IV studies.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

JSS Medical Research

St-Laurent, Quebec, Canada

Category Company
Founded 1985
Sector Life Science
DESCRIPTION

JSS Medical Research is a full-service clinical research organization (CRO) with strong academic affiliations offering a wide range of services internationally. One of their distinguishing attributes is their methodological knowledge and expertise in the design and execution of clinical studies. These include all phases of development, such as Phase I, II and III, and post-approval studies. The breadth of their experience enables our clients to collaborate with the same partner throughout the product lifecycle. JSS Medical Research was formed in 1985 and is based in St-Laurent, Quebec.


DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 4 of 4
Country: Poland M&A 1 of 1
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-05-05 Max Neeman International

Cary, North Carolina, United States

Max Neeman International, Inc. is a full service CRO offering solutions for Phase II – IV clinical trials to pharmaceutical, biotechnology, generic and device companies.

Buy -